150 related articles for article (PubMed ID: 11077221)
1. New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.
Richter M; Skupin M; Grabs R; Schramm D; Richter H; Olbrich HG
J Heart Lung Transplant; 2000 Nov; 19(11):1047-55. PubMed ID: 11077221
[TBL] [Abstract][Full Text] [Related]
2. Do vascular compartments differ in the development of chronic rejection? AT(1) blocker candesartan versus Ace blocker enalapril in an experimental heart transplant model.
Richter M; Richter H; Skupin M; Mohr FW; Olbrich HG
J Heart Lung Transplant; 2001 Oct; 20(10):1092-8. PubMed ID: 11595564
[TBL] [Abstract][Full Text] [Related]
3. Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy.
Richter MH; Richter HR; Olbrich HG; Mohr FW
Transpl Int; 2003 Jan; 16(1):26-32. PubMed ID: 12545338
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U
Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
[TBL] [Abstract][Full Text] [Related]
5. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats.
Taylor K; Patten RD; Smith JJ; Aronovitz MJ; Wight J; Salomon RN; Konstam MA
J Cardiovasc Pharmacol; 1998 May; 31(5):654-60. PubMed ID: 9593063
[TBL] [Abstract][Full Text] [Related]
6. Effects of enalapril and L-158809 on myocardial beta-adrenergic receptor density in transplanted rat hearts.
Nakame T; Iguchi A; Tabayashi K
Eur Surg Res; 2001; 33(4):297-302. PubMed ID: 11684837
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
[TBL] [Abstract][Full Text] [Related]
8. Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension.
Kalliovalkama J; Kähönen M; Tolvanen JP; Wu X; Voipio J; Pekki A; Doris PA; Ylitalo P; Pörsti I
Pharmacol Toxicol; 2000 Jan; 86(1):36-43. PubMed ID: 10720105
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 1 receptor blockade after cardiac transplantation reduced the incidence and severity of transplant vasculopathy in an animal-based study.
Richter MH; Richter H; Barten M; Schramm D; Gummert J; Mohr FW; Skupin M; Olbrich HG
Transplant Proc; 2002 Aug; 34(5):1484-5. PubMed ID: 12176450
[No Abstract] [Full Text] [Related]
10. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
Makino N; Sugano M; Otsuka S; Hata T
Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
Magga J; Kalliovalkama J; Romppanen H; Vuolteenaho O; Pörsti I; Kähönen M; Tolvanen JP; Ruskoaho H
J Hypertens; 1999 Nov; 17(11):1543-52. PubMed ID: 10608466
[TBL] [Abstract][Full Text] [Related]
12. TCV-116 reduces chronic rejection in a rat heterotopic cardiac transplant model.
Richter M; Westphal M; Maybaum B; Richter H; Skupin M; Mohr FW; Olbrich HG
Transplant Proc; 1999; 31(1-2):106-7. PubMed ID: 10083031
[No Abstract] [Full Text] [Related]
13. Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats.
Richer C; Bruneval P; Ménard J; Giudicelli JF
Hypertension; 1998 Feb; 31(2):692-8. PubMed ID: 9461242
[TBL] [Abstract][Full Text] [Related]
14. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.
Otsuka S; Sugano M; Makino N; Sawada S; Hata T; Niho Y
Hypertension; 1998 Sep; 32(3):467-72. PubMed ID: 9740612
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril.
Furukawa Y; Matsumori A; Hirozane T; Sasayama S
Circulation; 1996 Jan; 93(2):333-9. PubMed ID: 8548907
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft.
Noris M; Azzollini N; Pezzotta A; Mister M; Benigni A; Marchetti G; Gagliardini E; Perico N; Remuzzi G
J Am Soc Nephrol; 2001 Sep; 12(9):1937-1946. PubMed ID: 11518788
[TBL] [Abstract][Full Text] [Related]
17. The effect of enalapril on skin flap viability is independent of angiotensin II AT1 receptors.
Pazoki-Toroudi H; Ajami M; Habibey R; Hajiaboli E; Firooz A
Ann Plast Surg; 2009 Jun; 62(6):699-702. PubMed ID: 19461289
[TBL] [Abstract][Full Text] [Related]
18. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P
Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051
[TBL] [Abstract][Full Text] [Related]
19. Captopril reduces graft coronary artery disease in a rat heterotopic transplant model.
Kobayashi J; Crawford SE; Backer CL; Zales VR; Takami H; Hsueh C; Huang L; Mavroudis C
Circulation; 1993 Nov; 88(5 Pt 2):II286-90. PubMed ID: 8222167
[TBL] [Abstract][Full Text] [Related]
20. Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat.
Huang W; Alhenc Gelas F; Osborne-Pellegrin MJ
Circ Res; 1998 May; 82(8):879-90. PubMed ID: 9576107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
